Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from BioNxt Solutions ( (TSE:BNXT) ) is now available.
BioNxt Solutions Inc. has successfully closed the final tranche of its non-brokered private placement of unsecured convertible debentures, raising a total of $3,000,000. The funds raised will be allocated towards product development, intellectual property filings, and general working capital, potentially enhancing the company’s market positioning and operational capabilities.
More about BioNxt Solutions
BioNxt Solutions Inc. operates in the biotechnology industry and focuses on product development, intellectual property filings, and general working capital. The company is listed on multiple exchanges, including the Canadian Securities Exchange, and is involved in financing activities to support its operations.
YTD Price Performance: -10.36%
Average Trading Volume: 10,336
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $32.39M
Find detailed analytics on BNXT stock on TipRanks’ Stock Analysis page.